{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:43:42Z","timestamp":1792489422726,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.kint.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:27:26Z","timestamp":1787786846000},"page":"1126-1140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes from the International Society of Nephrology forum on complement therapeutics in C3 glomerulopathy and IgA nephropathy"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4718-0072","authenticated-orcid":false,"given":"David","family":"Kavanagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areefa","family":"Alladin-Karan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-606X","authenticated-orcid":false,"given":"Suceena","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Chauvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Kay","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Terence","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Fakhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux\u2011Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-1579","authenticated-orcid":false,"given":"Daniel P.","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Garred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Lafayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4242-3154","authenticated-orcid":false,"given":"Alison L.T.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Nester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evang\u00e9line","family":"Pillebout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather N.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-2811","authenticated-orcid":false,"given":"Dana V.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4885-7957","authenticated-orcid":false,"given":"Ian S.D.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5639-0210","authenticated-orcid":false,"given":"Brad H.","family":"Rovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2448-1959","authenticated-orcid":false,"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin K.S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Maville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A.","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia Eleanor","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Boor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haresh","family":"Selvaskandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Java","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia","family":"Peruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes A.H.M.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Kaartinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"J\u00f3zsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Duineveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alconcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu K.","family":"Bakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leal","family":"Herlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Wadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Caravaca-Font\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack F.","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney C.W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Zurowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"O\u2019Shaughnessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Durkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.K.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyeok","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole CAJ.","family":"van de Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Daina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Licht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muh Geot","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Eng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Daha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Ariceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Willcocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Fellstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"El Sissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Shaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alhasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.08.007_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy\u2014understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood.2022018833","article-title":"Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study","volume":"142","author":"Brocklebank","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.kint.2026.08.007_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.kint.2024.12.016","article-title":"The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndrome","volume":"107","author":"Smith-Jackson","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2026.08.007_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1537974","article-title":"Factor B as a therapeutic target for the treatment of complement-mediated diseases","volume":"16","author":"Kavanagh","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2026.08.007_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molimm.2018.06.008","article-title":"Developments in anti-complement therapy; from disease to clinical trial","volume":"102","author":"Harris","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2026.08.007_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ekir.2024.09.030","article-title":"Efficacy and safety of pegcetacoplan in kidney transplant recipients with recurrent complement 3 glomerulopathy or primary immune complex membranoproliferative glomerulonephritis","volume":"10","author":"Bomback","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib8","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1016\/j.ekir.2023.09.017","article-title":"Efficacy and safety of iptacopan in patients with C3 glomerulopathy","volume":"8","author":"Wong","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib9","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1056\/NEJMoa2501510","article-title":"Trial of pegcetacoplan in C3 glomerulopathy and immune-complex MPGN","volume":"393","author":"Fakhouri","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.08.007_bib10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(25)01148-1","article-title":"Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study","volume":"406","author":"Kavanagh","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2026.08.007_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ekir.2025.10.020","article-title":"Current and emerging therapies for C3 glomerulopathy and primary (idiopathic) immune complex membranoproliferative glomerulonephritis","volume":"11","author":"Kavanagh","year":"2026","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.kint.2026.08.007_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","article-title":"The pathogenesis of IgA nephropathy and implications for treatment","volume":"21","author":"Cheung","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.kint.2024.05.015","article-title":"The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"106","author":"Vivarelli","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2215\/CJN.0000000000000384","article-title":"Phase 2 trial of cemdisiran in adult patients with IgA nephropathy: a randomized controlled trial","volume":"19","author":"Barratt","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2410316","article-title":"Alternative complement pathway inhibition with iptacopan in IgA nephropathy","volume":"392","author":"Perkovic","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.08.007_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.kint.2023.09.027","article-title":"Results of a randomized double-blind placebo-controlled phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy","volume":"105","author":"Zhang","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1681\/ASN.0000000534","article-title":"Efficacy and safety of ravulizumab in IgA nephropathy: a phase 2 randomized double-blind placebo-controlled trial","volume":"36","author":"Lafayette","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf022","article-title":"Acquired drivers of C3 glomerulopathy","volume":"18","author":"Welsh","year":"2025","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2026.08.007_bib20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","article-title":"Therapeutic targeting of the complement system: from rare diseases to pandemics","volume":"73","author":"Garred","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.kint.2026.08.007_bib21","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1681\/ASN.2012020166","article-title":"A hybrid CFHR3-1 gene causes familial C3 glomerulopathy","volume":"23","author":"Malik","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1681\/ASN.2015040385","article-title":"High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies","volume":"27","author":"Bu","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib23","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1681\/ASN.2013070732","article-title":"Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN","volume":"25","author":"Wong","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1159\/000527166","article-title":"Baseline clinical characteristics and complement biomarkers of patients with C3 glomerulopathy enrolled in two phase 2 studies investigating the factor D inhibitor danicopan","volume":"53","author":"Podos","year":"2022","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ekir.2023.11.025","article-title":"Defining nephritic factors as diverse drivers of systemic complement dysregulation in C3 glomerulopathy","volume":"9","author":"Hauer","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib26","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2215\/CJN.01820214","article-title":"Defining the complement biomarker profile of C3 glomerulopathy","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1589674","article-title":"Factor H-related 1 and heparan sulfate architecture contribute to complement dysregulation in C3 glomerulopathy","volume":"16","author":"Slagle","year":"2025","journal-title":"Front Immunol"},{"issue":"4S","key":"10.1016\/j.kint.2026.08.007_bib28","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae395","article-title":"Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity","volume":"18","author":"Nurmi","year":"2025","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2026.08.007_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1681\/ASN.2019040433","article-title":"Large-scale whole-genome sequencing reveals the genetic architecture of primary membranoproliferative GN and C3 glomerulopathy","volume":"31","author":"Levine","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1681\/ASN.0000000000000499","article-title":"Functional characterization of anti-C3bBb autoantibodies and C3 glomerulopathy phenotype","volume":"36","author":"Roquigny","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib32","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2215\/CJN.00320121","article-title":"C3 glomerulopathy and related disorders in children: etiology-phenotype correlation and outcomes","volume":"16","author":"Wong","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ki.1979.50","article-title":"Recurrence of dense deposits in transplanted kidneys: I. Sequential survey of the lesions","volume":"15","author":"Droz","year":"1979","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/ndt\/gfae243","article-title":"Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN","volume":"40","author":"Roquigny","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.08.007_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152410","article-title":"Complement factor I: regulatory nexus, driver of immunopathology, and therapeutic","volume":"228","author":"Hallam","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.kint.2026.08.007_bib36","article-title":"Functional characterization of rare genetic variants in the N-terminus of complement factor H in aHUS, C3G, and AMD","volume":"11","author":"Wong","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2026.08.007_bib37","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2215\/CJN.15241219","article-title":"Mycophenolate mofetil in C3 glomerulopathy and pathogenic drivers of the disease","volume":"15","author":"Caravaca-Fontan","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib38","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2215\/CJN.0000000000000252","article-title":"Rare variants in complement gene in C3 glomerulopathy and immunoglobulin-mediated membranoproliferative GN","volume":"18","author":"Meuleman","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/81677","article-title":"IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23","volume":"26","author":"Gharavi","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2026.08.007_bib40","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1681\/ASN.2007020241","article-title":"Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36","volume":"18","author":"Paterson","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib41","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1086\/510135","article-title":"Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci","volume":"79","author":"Bisceglia","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.kint.2026.08.007_bib42","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","article-title":"Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy","volume":"55","author":"Kiryluk","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2026.08.007_bib43","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2215\/CJN.0000000000000505","article-title":"Developing therapies for C3 glomerulopathy: report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group","volume":"19","author":"Nester","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2215\/CJN.16801221","article-title":"Association of histologic parameters with outcome in C3 glomerulopathy and idiopathic immunoglobulin-associated membranoproliferative glomerulonephritis","volume":"17","author":"Lomax-Browne","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib47","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib49","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2215\/CJN.11521210","article-title":"Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the Oxford classification","volume":"6","author":"Shi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib50","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1681\/ASN.2016040433","article-title":"A multicenter study of the predictive value of crescents in IgA nephropathy","volume":"28","author":"Haas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ekir.2021.10.007","article-title":"A novel scoring system based on Oxford classification indicating steroid therapy use for IgA nephropathy","volume":"7","author":"Itami","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib52","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.kint.2024.03.011","article-title":"Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy","volume":"105","author":"Bellur","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib53","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40620-022-01363-4","article-title":"Predictive prognostic value of glomerular C3 deposition in IgA nephropathy","volume":"36","author":"Xie","year":"2023","journal-title":"J Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1681\/ASN.2017030258","article-title":"Cluster analysis identifies distinct pathogenetic patterns in C3 glomerulopathies\/immune complex-mediated membranoproliferative GN","volume":"29","author":"Iatropoulos","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib56","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ndt\/gfae245","article-title":"Acquired and genetic determinants of disease phenotype and therapeutic strategies in C3 glomerulopathy and immunoglobulin-associated MPGN","volume":"40","author":"Meuleman","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.08.007_bib57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ekir.2023.10.022","article-title":"Iptacopan in idiopathic immune complex-mediated membranoproliferative glomerulonephritis: protocol of the APPARENT multicenter, randomized phase 3 study","volume":"9","author":"Vivarelli","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib59","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.ekir.2022.07.004","article-title":"Alternative complement pathway inhibition with iptacopan for the treatment of C3 glomerulopathy-study design of the APPEAR-C3G trial","volume":"7","author":"Bomback","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib62","series-title":"Ravulizumab in IgA nephropathy: a prespecified interim analysis of a randomized phase 3 trial (I CAN)","author":"Barratt","year":"2026"},{"key":"10.1016\/j.kint.2026.08.007_bib64","article-title":"The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies","volume":"3","author":"Cheung","year":"2023","journal-title":"Front Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12882-020-01888-5","article-title":"A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy","volume":"21","author":"Wright","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib66","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2215\/CJN.0000000000000398","article-title":"Histologic and clinical factors associated with kidney outcomes in IgA vasculitis nephritis","volume":"19","author":"Barbour","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib67","article-title":"Genome-wide studies define new genetic mechanisms of IgA vasculitis","author":"Liu","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.kint.2026.08.007_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2025.151571","article-title":"IgA vasculitis and IgA nephropathy: two sides of the same coin?","volume":"44","author":"Pillebout","year":"2024","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib69","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1096\/fj.07-8719com","article-title":"Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury","volume":"22","author":"Sheerm","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2026.08.007_bib70","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1681\/ASN.2006121343","article-title":"Complement C5 mediates experimental tubulointerstitial fibrosis","volume":"18","author":"Boor","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib71","doi-asserted-by":"crossref","first-page":"F35","DOI":"10.1152\/ajprenal.00060.2017","article-title":"Complement C5a receptors C5L2 and C5aR in renal fibrosis","volume":"314","author":"Martin","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.08.007_bib72","article-title":"Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases","volume":"14","author":"Xiao","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib73","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1172\/JCI83000","article-title":"Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury","volume":"126","author":"Farrar","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2026.08.007_bib74","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1096\/fj.201901582R","article-title":"l-fucose prevention of renal ischaemia\/reperfusion injury in mice","volume":"34","author":"Howard","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2026.08.007_bib75","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/imr.13144","article-title":"Local complement synthesis-A process with near and far consequences for ischemia reperfusion injury and transplantation","volume":"313","author":"Nauser","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2026.08.007_bib76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2018.12.046","article-title":"C5 convertase blockade in membranoproliferative glomerulonephritis: a single-arm clinical trial","volume":"74","author":"Ruggenenti","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.08.007_bib77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2017.11.019","article-title":"Patterns of clinical response to eculizumab in patients with C3 glomerulopathy","volume":"72","author":"Le Quintrec","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.08.007_bib78","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1681\/ASN.0000000526","article-title":"Safety and efficacy of avacopan in patients with complement 3 glomerulopathy: randomized, double-blind clinical trial","volume":"36","author":"Bomback","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib79","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000527167","article-title":"Clinical outcomes of patients with C3G or IC-MPGN treated with the factor D inhibitor danicopan: final results from two phase 2 studies","volume":"53","author":"Nester","year":"2022","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib80","doi-asserted-by":"crossref","DOI":"10.1177\/20543581251322571","article-title":"Is childhood IgA nephropathy different from adult IgA nephropathy? A narrative review","volume":"12","author":"Alladin-Karan","year":"2025","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.kint.2026.08.007_bib81","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00467-022-05725-9","article-title":"Association between glomerular C4d deposition, proteinuria, and disease severity in children with IgA nephropathy","volume":"38","author":"Zhou","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib82","article-title":"Immunosuppressive therapy for IgA nephropathy in children","volume":"6","author":"Alladin","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2026.08.007_bib83","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2215\/CJN.0000000000000474","article-title":"C3 glomerulopathy recurs early after kidney transplantation in serial biopsies performed within the first 2 years after transplantation","volume":"19","author":"Tarrag\u00f3n","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib84","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/ndt\/gfac148","article-title":"Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation","volume":"38","author":"Caravaca-Font\u00e1n","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.08.007_bib85","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.ajkd.2018.09.002","article-title":"Kidney transplantation in C3 glomerulopathy: a case series","volume":"73","author":"Regunathan-Shenk","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.08.007_bib86","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib87","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.mayocp.2018.05.019","article-title":"C3 glomerulopathy: ten years' experience at Mayo Clinic","volume":"93","author":"Ravindran","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.kint.2026.08.007_bib88","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40620-019-00672-5","article-title":"Outcome of C3 glomerulopathy patients: largest single-centre experience from South Asia","volume":"33","author":"Kumar","year":"2020","journal-title":"J Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib89","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/ndt\/gfz021","article-title":"Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy","volume":"34","author":"Frangou","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.08.007_bib90","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ckj\/sfw020","article-title":"Kidney transplant outcomes in familial C3 glomerulopathy","volume":"9","author":"Wong","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2026.08.007_bib91","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12882-015-0219-x","article-title":"Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification","volume":"17","author":"Alasfar","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib92","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1681\/ASN.2013070715","article-title":"Clinical findings, pathology, and outcomes of C3GN after kidney transplantation","volume":"25","author":"Zand","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.08.007_bib93","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/ndt\/14.7.1723","article-title":"Renal transplantation in patients with dense deposit disease: morphological characteristics of recurrent disease and clinical outcome","volume":"14","author":"Andresdottir","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.08.007_bib94","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3389\/fimmu.2019.01332","article-title":"Immunoglobulin A nephropathy. Recurrence after renal transplantation","volume":"10","author":"Moroni","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2026.08.007_bib95","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.kint.2017.03.015","article-title":"Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes","volume":"92","author":"Allen","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.08.007_bib97","doi-asserted-by":"crossref","first-page":"164","DOI":"10.12688\/wellcomeopenres.16071.1","article-title":"Crescentic glomerulonephritis: What's different in South Asia? A single center observational cohort study","volume":"5","author":"Alexander","year":"2020","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.kint.2026.08.007_bib98","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ekir.2020.11.026","article-title":"Epidemiology, baseline characteristics and risk of progression in the first South-Asian prospective longitudinal observational IgA nephropathy cohort","volume":"6","author":"Alexander","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ekir.2021.11.012","article-title":"Three-year clinical outcomes of the first South Asian prospective longitudinal observational IgA nephropathy cohort","volume":"7","author":"Alexander","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.08.007_bib101","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa2512133","article-title":"Sibeprenlimab in IgA nephropathy - interim analysis of a phase 3 trial","volume":"394","author":"Perkovic","year":"2026","journal-title":"N Engl J Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826007118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826007118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:32:38Z","timestamp":1792488758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826007118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0085253826007118"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.08.007","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes from the International Society of Nephrology forum on complement therapeutics in C3 glomerulopathy and IgA nephropathy","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}